Skip to content

Clinical trials

Phase 3 Biliary Tract Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Biliary Tract Neoplasms Phase: Phase 3 Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20121
20143
20181
20193
20211
20234
20244
20251
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting10
Completed7
Active, not recruiting4
Terminated2
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Sichuan Baili Pharmaceutical Co., Ltd.2
UNICANCER2
3D Medicines (Sichuan) Co., Ltd.1
Akeso1
Azienda Ospedaliero-Universitaria di Parma1
Fudan University1
Helsinn Healthcare SA1
InnoPharmax Inc.1
J-Pharma Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Biliary Tract Neoplasms25
Cholangiocarcinoma8
Gallbladder Neoplasms6
Bile Duct Neoplasms2
Pancreatic Neoplasms2
Acrocephalosyndactylia1
Adenocarcinoma1
Carcinoma, Non-Small-Cell Lung1
Digestive System Neoplasms1
Duodenal Neoplasms1

Trials

Showing 76 to 25 of 25. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.